🇺🇸 Escitalopram oxylate in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 11

Most-reported reactions

1. Diarrhoea — 2 reports (18.18%)
2. Abdominal Tenderness — 1 report (9.09%)
3. Alopecia — 1 report (9.09%)
4. Anxiety — 1 report (9.09%)
5. Arteriosclerosis — 1 report (9.09%)
6. Back Disorder — 1 report (9.09%)
7. Bone Cancer — 1 report (9.09%)
8. Cardiac Arrest — 1 report (9.09%)
9. Chest Pain — 1 report (9.09%)
10. Crying — 1 report (9.09%)

Source database →

Frequently asked questions

Is Escitalopram oxylate approved in United States?

Escitalopram oxylate does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Escitalopram oxylate in United States?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.